FDA
approval
· 2022-06-27
FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
Summary
FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for HUMULIN N (INSULIN HUMAN)